CSF1 and cancer: Therefore, as CSF1 and FGF signals are both involved in the accumulation of tumor- promoting M2 macrophages, MDSCs, and Tregs (44), the dual inhibition of CSF1R and FGFR1 by sulfatinib may be more effective for cancer therapy than selective CSF1R inhibition.